Avastin in Stage II and III Colon Cancer

In the plenary session at ASCO this year there was a presentation of a large NASBP trial which tested whether the addition of Avastin® (bevacizumab) to 6 months of FOLFOX would decrease tumor recurrence.

The data suggested that there was no benefit with the addition of Avastin, which was given not only for 6 months along with chemotherapy but 6 months in addition to FOLFOX for a total of 12 months. Continue reading…

Posted by Heinz-Josef Lenz, MD on June 7th, 2009
Posted in: From the Desk of Dr. Lenz | 5 Comments »
Tags: adjuvant chemotherapy, ASCO 2009, Avastin, Treating Colorectal Cancer

Adjuvant Treatment Does Not Have Negative Impact on Elderly Quality of Life

Colon and rectal cancer patients 75 years old and older who are treated with chemotherapy or radiation don’t report any poorer quality of life than older patients who don’t have such therapy.  Patients who had chemotherapy said that their physical functioning was better than that reported by those who didn’t receive chemo. Continue reading…

Posted by Kate Murphy on August 5th, 2008
Posted in: Research & Treatment News | 2 Comments »
Tags: adjuvant chemotherapy, elderly, quality of life, radiotherapy